Posted inBiotechnology
Posted inGenetics
Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration
A cancer cell (shown in white) being attacked by two T cells (red). Astellas Pharma has ended a six-year-old collaboration…





















